Work

217P A phase II study of docetaxel and pembrolizumab plus Interleukin-12 gene therapy in non-metastatic, anthracycline-refractory triple-negative breast cancer (INTEGRAL)

Year: 2025

Type: article

Source: ESMO Open

DOI: 10.1016/j.esmoop.2025.104771

Authors: P. Niravath, K. Sun, H.P. Mai, J. Guan, M. Li, J. Deng, W. Qian, L. Guzman, I. Uzair, S. Mathur, J. Chang

Institution: Houston Methodist

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,910

OpenAlex ID: W4410455962

FWCI:

Cites:

Cited by:

Related to: 10